The effects of antidepressants in parkinson's disease: A meta-analysis

被引：20
|
作者：
Frisina, Pasquale G. [1 ,2 ]
Tenenbaum, Harriet R. [3 ]
Borod, Joan C. [4 ,5 ]
机构：
[1] Jewish Home & Hosp, Dept Med Res, Leir Parkinsons Dis Program, Lifecar Syst, New York, NY 10025 USA
[2] Mt Sinai Sch Med, Dept Geriatr & Adult Dev, New York, NY USA
[3] Kingston Univ, Dept Psychol, Kingston upon Thames KT1 2EE, Surrey, England
[4] CUNY Queens Coll, Dept Psychol, Flushing, NY 11367 USA
[5] Grad Ctr City Univ New York, Flushing, NY 11367 USA
来源：
INTERNATIONAL JOURNAL OF NEUROSCIENCE | 2008年 / 118卷 / 05期
关键词：
depression; meta-analysis; Parkinson's disease; treatment;
D O I：
10.1080/00207450701239418
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
This study explored the therapeutic effect of antidepressants in Parkinson's disease (PD) using a meta-analysis. Altogether, 24 placebo-controlled trials qualified for inclusion and revealed that tricyclic antidepressants (TCAs) had a greater antidepressant effect relative to selective serotonin reuptake inhibitors (SSRIs), Qb(1) = 8.87, p < .01, and the mono-amine-oxidase inhibitor, selegiline, Qb(1) = 7.90, p < .01. Whereas TCAs produced a significant side effect profile (odds ratio = 3.07), adverse events were negligible with SSRIs (odds ratio = 1.83) and selegeline (odds ratio = 1.63). Antidepressants can be beneficial for patients with PD. However, the choice of antidepressants needs to take depressive symptomatologies into account while monitoring side effects.
引用
收藏
页码：667 / 682
页数：16
相关论文
共 50 条
  • [41] Course of cognitive decline in Parkinson's disease: A meta-analysis
    Muslimovic, Dino
    Schmand, Ben
    Speelman, Johannes D.
    De Haan, Rob J.
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2007, 13 (06) : 920 - 932
  • [42] Neuropeptide Alterations in Parkinson's disease (PD) : A Meta-Analysis
    Muneer, M. A.
    Suresh, V.
    Aujla, S.
    Khare, A.
    Gowda, P.
    Ghosh, V.
    Dave, T.
    MOVEMENT DISORDERS, 2024, 39 : S842 - S842
  • [43] Antidiabetic Agents for Treatment of Parkinson's Disease: A Meta-Analysis
    Wang, Shu-Yi
    Wu, Shey-Lin
    Chen, Ta-Cheng
    Chuang, Chieh-Sen
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (13) : 1 - 11
  • [44] Association of orthostatic hypotension with Parkinson’s disease: a meta-analysis
    Feifei Mu
    Qian Jiao
    Xixun Du
    Hong Jiang
    Neurological Sciences, 2020, 41 : 1419 - 1426
  • [45] Empathy and theory of mind in Parkinson's disease: A meta-analysis
    Coundouris, Sarah P.
    Adams, Alexandra G.
    Henry, Julie D.
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2020, 109 : 92 - 102
  • [46] Cytokine Gene Polymorphisms and Parkinson's Disease: A Meta-Analysis
    Chu Ketan
    Zhou Xiao
    Luo Ben-yan
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2012, 39 (01) : 58 - 64
  • [47] Frailty in Parkinson's disease: A systematic review and meta-analysis
    Mcmillan, Jacqueline M.
    Michalchuk, Quentin
    Goodarzi, Zahra
    CLINICAL PARKINSONISM & RELATED DISORDERS, 2021, 4
  • [48] Antidepressant studies in Parkinson's disease: A review and meta-analysis
    Weintraub, D
    Morales, KH
    Moberg, PJ
    Bilker, WB
    Balderston, C
    Duda, JE
    Katz, IR
    Stern, MB
    MOVEMENT DISORDERS, 2005, 20 (09) : 1161 - 1169
  • [49] Prevalence of oropharyngeal dysphagia in Parkinson's disease: A meta-analysis
    Kalf, J. G.
    de Swart, B. J. M.
    Bloem, B. R.
    Munneke, M.
    PARKINSONISM & RELATED DISORDERS, 2012, 18 (04) : 311 - 315
  • [50] Fatigue in Parkinson's disease: A systematic review and meta-analysis
    Siciliano, Mattia
    Trojano, Luigi
    Santangelo, Gabriella
    De Micco, Rosa
    Tedeschi, Gioacchino
    Tessitore, Alessandro
    MOVEMENT DISORDERS, 2018, 33 (11) : 1712 - 1723
12345